entertainment -WSS

entertainment

author：entertainment 2025-10-01 05:38:21 - browse：3

Andrew Trister, an oncologist and veteran of big technology companies and research, is Verily's new chief scientific officer.

As Verily aims to get on track, the Alphabet life science company has hired Andrew Trister, an oncologist and veteran of big technology companies and research, as its new chief scientific officer.

Trister will lead Verily’s population health initiatives, including public health solutions like the company’s ongoing work to combat disease-carrying mosquito populations and a program that helps wastewater treatment plants monitor for pathogens. He will also consult across Verily’s diverse projects.

Trister’s focus on public health will build on his recent role as a deputy director at the Bill and Melinda Gates Foundation, where he led digital health, including a project to build tech infrastructure to help with malaria testing. Trister also led the foundation’s Covid-19 response. In 2016, he was an early health hire at Apple. There, he worked on programs like a heart health study with Janssen, an app to promote healthy habits with Aetna, and research into digital biomarkers for Alzheimer’s disease with Eli Lilly and Evidation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

WSS

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Why the quest to eradicate polio has stumbled

Study gives hint on South Asians’ higher risk of cardiovascular disease

How the messy conversation about Dolly changed bioethics

Covid’s new normal has set in amid another rise in cases

Wikipedia

entertainment

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

Congress must protect the remaining independent doctors

Anesthesiologist group: stop taking Ozempic before surgery

Why the drug industry's warnings on the IRA's impact fall short

Activists slam private health insurers over coverage restrictions

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Tori Bowie and the unacceptable rates of Black maternal death

People with substance use disorder deserve online privacy

Novavax promises a turnaround & Lilly roils the obesity market

Bernie Sanders gets little from pharma CEOs on drug prices

focus

'A game

Bernie Sanders gets little from pharma CEOs on drug prices

Congress must protect the remaining independent doctors

Ebola vaccine can save some who are already sick, per new study

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Abbott's new heart device gets FDA advisory panel nod

explore

knowledge

focus

hotspot